// App-Quantinova.ai

P031 : Development Of Silent Brain Lesions In Pediatric Patients With Antibodies To Myelin Oligodendrocyte Glycoprotein

Researchers

Presenter

  • G. Fadda

Principal Investigators

  • J. O'Mahony

  • R. A. Brown

  • D. Castro

  • G. Longoni

  • L. Verhey

  • H. Branson

  • E. A. Yeh

  • R. A. Marrie

  • D. L. Arnold

  • P. Waters

  • B. Banwell

  • A. Bar-Or

Medical Centers

  • Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States, Philadelphia, PA

  • Institute of Health Policy, Management and Evaluation, the University of Toronto/The Hospital for Sick Children, Toronto, ON, CANADA

  • ShadowLab Research Inc, Toronto, ON, CANADA

  • Diagnostic Imaging, Neurosciences and Mental Health, SickKids Research Institute, Toronto, ON, CANADA

  • Department of Paediatrics, University of Toronto, Toronto, ON

  • College of Medicine, Central Michigan University, Mount Pleasant, MI, United States,

  • Internal Medicine and Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, CANADA

  • Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, CANADA

  • Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, UK, United kingdom

  • Division of Child Neurology, Department of Neurology, The Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

  • Center for NeuroInflammation and Experimental Therapeutics, and Multiple Sclerosis Division, Departm, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Locations

  • United States

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A